Trial Profile
Phase IIb/III trial of ISR-48 in newly diagnosed HIV-infected patients
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 27 Mar 2018
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications HIV-1 infections
- Focus Registrational; Therapeutic Use
- Sponsors Immune System Regulation
- 27 Mar 2018 New trial record
- 01 Dec 2017 Accoding to Immune System Regulation media release, discussions are still under way to find solutions to the ethical aspects of this study and alternative countries for the study, including China and Far East Asia.